In June 2019, 71 exceptional individuals, representing 32 different nationalities, were carefully selected to join our first program in London. After just 2 months we invested £1.56 million in 13 different companies that were generated in that program, 30% of which have a female co-founder. At our first London Demo Day, these companies pitched in front of a full house of 400 investors at the iconic Royal Institution in Mayfair.

During the day, we also had the pleasure to invite Reshma Sohoni, founder and managing director at SeedCamp, for a fireside chat together with our CEO and founder Magnus Grimeland. Moderated by Amy Lewin from Sifted, they shared their insights on the European startup and venture capital scene, how it has evolved in the last few years and what's to come. Get a first glimpse at the 13 companies below.

"You have 3 months to start your company from scratch. You have to find your co-founder, pick a problem, and validate your solution with customers. If all  goes well, you'll get 3 more months to complete building your MVP and generate traction before you pitch to investors. Ready? Go!"

In a global partnership, Antler is taking part in the Annual Investment Committee (AIM) Dubai summit in March. 6 Antler locations will hold a local startup pitch competition calling on all our portfolio companies in specific sectors.

Adam Ross is an entrepreneur participating in Antler's second Sydney program. Here's what he learned from participating in Design Sprints.

Sydney entrepreneur and PhD candidate Snow Li discusses what it was like to form new bonds in Week 1 of the Antler program

Global startup generator and early-stage venture capital firm Antler and the National University of Singapore (NUS), via the Graduate Research Innovation Programme (GRIP), has launched an Executive Programme to enable more entrepreneurs to build successful deep tech startups. The bespoke six-month part-time programme will combine the best of both organisations including platforms, funding and ecosystems.

‍

21% of Antler Sydney's second cohort have previously exited a company as a founder or executive.

81 of Australia's most entrepreneurial tech and commercial leaders are ready to build the next wave of tech.

The group of companies invested in the third Singapore program drive disruption in e.g., B2B SaaS, e-commerce, GreenTech, PropTech and HealthTech.

Many of us struggle to maintain boundaries from our work and our personal life. We discussed this with mindfulness expert Johanna Dahlman about how you can make sure you stick to your boundaries as 2020 get's underway.

Antler has raised a further US$50m into its Global funds, supported by high profile investors, including Facebook co-founder Eduardo Saverin.

Here we are, 2020. New year, new decade, new you right? Your resolution this year is the same as every year, to eat healthier and have a better diet. You've got the brown rice, chicken and green veg meal prepped for the next month and you're feeling good that you're going to stick to it this year. Thing is...What if that brown rice, chicken and veg is actually not responding well with your body?

‍

People join Antler for many different reasons, but all come in with a common goal, "I want to build". In an era powered by the internet when successes all look the same, the initial steps of early-stage startups are one of it's most inspiring parts. Podcaster, Alex Chisnall sat down with 5 Antler entrepreneurs from Amsterdam on their motivations and entrepreneurial journeys in the latest episode of his "Screw it, just do it" podcast.

‍

Big companies, small companies, political parties - everybody spends large  amounts of money on digital advertising every day, trying to increase their  brand awareness and sales. However, some of them should not have to, given  that they already have large, loyal communities that are happy to support  their cause for free - yet they don't. Why is that?

‍

As the medical field keeps evolving with new emerging technologies, the future of medical care is prepared for constant and rapid change with advancements poised to make the industry even more human-focused than it is currently. Better trained physicians, improved accuracy in disease targeting coupled with improving medical standards globally have rendered most diseases no longer life-threatening.

‍